Jeremy Squire, Ph.D.
As a cytogeneticist and the J.C. Boileau Grant Chair in Oncologic Pathology
at the University Health Network, Dr. Squire is involved in basic laboratory studies on cancer genetics of solid and hematologic cancer, translational research, and more recently, in investigations into mechanisms of chromosomal instability. Dr. Squire's program utilizes molecular, genomic and cytogenetic methods to provide
new information and hypotheses concerning the onset, cause, and progression
of cancer. His research program continues to involve close interactions between basic scientists and clinicians from the disciplines of pathology, oncology
and genetics. His laboratory has published well over 100 original peer-reviewed papers in the area of the molecular cytogenetics of solid tumours and leukemias.
Dr. Squire’s current research interests center on genomic alterations associated with preneoplasia and in chromosomal mechanisms that lead to the onset
of translocations, amplification and deletions in tumours.